ESR1 and breast carcinoma: Based on our results, no significant differences was observed in responsiveness of estrogen receptor positive (MCF-7) and negative (MDA-MB-468) toward sodium butyrate and apparently further studies are required to clarify the relevance of estrogen receptor in the sodium butyrate-induced apoptosis in breast cancer.